131 related articles for article (PubMed ID: 3261738)
1. Clonotypic analysis of the antibody response to the acetylcholine receptor in experimental autoimmune myasthenia gravis.
Brown RM; Krolick KA
J Neuroimmunol; 1988 Sep; 19(3):205-22. PubMed ID: 3261738
[TBL] [Abstract][Full Text] [Related]
2. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
Zoda T; Yeh TM; Krolick KA
J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: subsetting of serum antibodies by preparative isoelectric focusing.
Thompson PA; Krolick KA
Clin Immunol Immunopathol; 1992 Feb; 62(2):199-209. PubMed ID: 1730158
[TBL] [Abstract][Full Text] [Related]
4. Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen.
Yeh TM; Krolick KA
J Neuroimmunol; 1989 Sep; 24(1-2):133-42. PubMed ID: 2478576
[TBL] [Abstract][Full Text] [Related]
5. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
[TBL] [Abstract][Full Text] [Related]
6. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein.
McIntosh KR; Linsley PS; Bacha PA; Drachman DB
J Neuroimmunol; 1998 Jul; 87(1-2):136-46. PubMed ID: 9670855
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
11. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Huang J; Olsson T; He B; Link H
J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
[TBL] [Abstract][Full Text] [Related]
13. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.
Xiao BG; Lu CZ; Höjeberg B; Link H
J Neurol Sci; 1991 Sep; 105(1):118-23. PubMed ID: 1665503
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
Gomez CM; Richman DP
J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
[TBL] [Abstract][Full Text] [Related]
15. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes.
Zhang Y; Tzartos S
Immunology; 1992 Dec; 77(4):571-6. PubMed ID: 1283599
[TBL] [Abstract][Full Text] [Related]
16. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.
Verschuuren JJ; Graus YM; Theunissen RO; Yamamoto T; Vincent A; van Breda Vriesman PJ; De Baets MH
J Neuroimmunol; 1992 Feb; 36(2-3):117-25. PubMed ID: 1732277
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line.
Martino G; Twaddle G; Brambilla E; Grimaldi LM
Acta Neurol Scand; 1994 Jan; 89(1):18-22. PubMed ID: 8178622
[TBL] [Abstract][Full Text] [Related]
18. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH
Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
